Search results for "Virus strain"

showing 3 items of 3 documents

Antibodies for strain 2117-like vesiviruses (caliciviruses) in humans

2015

The vesivirus strain 2117 has been identified as contaminant of bioreactors used for production of human drugs, due to possible contamination of the reagents used for cell cultivation. Using an ELISA assay, antibodies specific for 2117-like viruses were detected in 32/410 (7.8%) human sera, indicating exposure to these viruses.

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaCancer ResearchAdolescentAntibodieCellAntibodies ViralAntibodiesCalicivirusesVesivirus strain 2117Young AdultCaliciviruseSeroepidemiologic StudiesVirologymedicineHumansVesivirusChildVesivirusAgedAged 80 and overbiologyStrain (chemistry)Infant NewbornInfantEnvironmental ExposureElisa assaySeroepidemiologic StudiesEnvironmental exposureMiddle AgedContaminationbiology.organism_classificationVirologyInfectious Diseasesmedicine.anatomical_structureChild Preschoolbiology.proteinFemaleAntibodies; Caliciviruses; Humans; Vesivirus strain 2117AntibodyHumanVirus Research
researchProduct

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

2014

Background: One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance mutations (TDRM) using data from the European Spread program.Methods: Clinical, epidemiological and virological data from 4317 patients newly diagnosed with HIV-1 infection between 2002 and 2007 were analysed. Patients were enrolled using a pre-defined sampling strategy.Results: The overall prevalence of TDRM in this period was 8.9% (95% CI: 8.1-9.8). Interestingly, significant changes over time in TDRM caused by the different drug classes were found. Whereas nucleoside resistance mutations remained con…

Malevirus strainResistanceHIV InfectionsDrug resistanceTHERAPYNucleoside Reverse Transcriptase InhibitorANTIRETROVIRAL DRUG-RESISTANCE0302 clinical medicineMedical microbiologyGenotypeMedicine and Health SciencesPrevalenceHIV Infection030212 general & internal medicineUNITED-KINGDOMPhylogeny0303 health sciencesCommunicable diseaseTransmission (medicine)adultvirus mutationUPDATED RECOMMENDATIONSvirus transmission3. Good healthEuropeInfectious Diseasesfemalerisk factorvirus resistanceFemaleNAIVE PATIENTSSOCIETY-USA PANELResearch ArticleHumanAdultmedicine.medical_specialtyGenotypeAnti-HIV AgentsVirusArticle03 medical and health sciencesSDG 3 - Good Health and Well-beingmaleMOLECULAR EPIDEMIOLOGYDrug Resistance Viralmedicineproteinase inhibitorHumansTransmissioncontrolled studyhumanmolecular phylogeny030304 developmental biologynonhumanMUTATIONSbusiness.industryAnti-HIV Agentnucleotide sequencenonnucleoside reverse transcriptase inhibitorHuman immunodeficiency virus 1 infectionVirologymajor clinical studyunindexed sequenceParasitology3121 General medicine internal medicine and other clinical medicineMutationHIV-1business
researchProduct

Dolphin morbillivirus epizootic resurgence, Mediterranean Sea

2008

In July 2007, > 100 striped dolphins, Stenella coeruleoalba, were found dead along the coast of the Spanish Mediterranean. Of 10 dolphins tested, 7 were positive for a virus strain closely related to the dolphin morbillivirus that was isolated during a previous epizootic in 1990.

Microbiology (medical)Mediterranean climateEpidemiologylcsh:MedicineStenella coeruleoalbalcsh:Infectious and parasitic diseasesDisease OutbreaksMediterranean seaStenellaMorbillivirusVirus strainbiology.animalMediterranean SeamedicineAnimalslcsh:RC109-216Epizooticre-emerging diseasebiologydolphinlcsh:RDispatchbiology.organism_classificationStenellamedicine.diseaseCetacean morbillivirusmorbillivirusFisheryInfectious DiseasesSpainMorbillivirus Infections
researchProduct